Shanghai Pharma Wants to Acquire US or European Pharma
publication date: Aug 16, 2011
Shanghai Pharmaceuticals is seeking to acquire a mid-sized US or European drugmaker, according to the company’s Chairman, Mingfang Lu. Shanghai Pharma wants to enlarge its supply of innovative drugs, he said, because the company sees patented products as a hedge against the price pressures affecting generic drugs in China. Lu summarized the situation by saying, "We hope to make structural improvements to our product portfolio by raising the proportion of innovative drugs, so as to better weather industry risks in the future.” More details....
Stock Symbol: (SHA: 601607) Share this with colleagues:
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.